BAX and BAK mediate p53-independent suppression of tumorigenesis

被引:133
作者
Degenhardt, K
Chen, GH
Lindsten, T
White, E
机构
[1] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ctr Adv Biotechnol & Med, Div Biochem & Mol Biol, Piscataway, NJ 08854 USA
[3] Canc Inst New Jersey, Piscataway, NJ 08854 USA
[4] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[7] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S1535-6108(02)00126-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BAX and BAK are essential regulators of proapoptotic signaling, and the disruption of apoptosis is linked to the development of cancer. To investigate the role of BAX and BAK in tumorigenesis, primary baby mouse kidney epithelial cells (BMKs) from wild-type, BAX-, BAK-, or BAK- and BAK-deficient mice were transformed by adenovirus El A and dominant-negative p53 (p53DD). In wild-type BMKs, the expression of El A and inactivation of p53 was sufficient for transformation but not tumorigenesis. In contrast, E1A- and p53DD-transformed BAX- and BAK-deficient BMKs formed highly invasive carcinomas. Transformed BMKs deficient for either BAX or BAK were also tumorigenic, but only when heterozygous for the remaining bax or bak allele, the expression of which was lost in most resulting tumors. Thus, BAX and BAK function to suppress tumorigenesis, and their deficiency was selected for in vivo.
引用
收藏
页码:193 / 203
页数:11
相关论文
共 58 条
[1]
Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria [J].
Antonsson, B ;
Montessuit, S ;
Lauper, S ;
Eskes, R ;
Martinou, JC .
BIOCHEMICAL JOURNAL, 2000, 345 :271-278
[2]
Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[3]
BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis [J].
Cheng, EHYA ;
Wei, MC ;
Weiler, S ;
Flavell, RA ;
Mak, TW ;
Lindsten, T ;
Korsmeyer, SJ .
MOLECULAR CELL, 2001, 8 (03) :705-711
[4]
BCL-2 BLOCKS P53-DEPENDENT APOPTOSIS [J].
CHIOU, SK ;
RAO, L ;
WHITE, E .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (04) :2556-2563
[5]
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[6]
Proteases to die for [J].
Cryns, V ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (11) :1551-1570
[7]
Bak and Bax function to limit adenovirus replication through apoptosis induction [J].
Cuconati, A ;
Degenhardt, K ;
Sundararajan, R ;
Anschel, A ;
White, E .
JOURNAL OF VIROLOGY, 2002, 76 (09) :4547-4558
[8]
WILD-TYPE P53 MEDIATES APOPTOSIS BY E1A, WHICH IS INHIBITED BY E1B [J].
DEBBAS, M ;
WHITE, E .
GENES & DEVELOPMENT, 1993, 7 (04) :546-554
[9]
Bax and Bak independently promote cytochrome c release from mitochondria [J].
Degenhardt, K ;
Sundararajan, R ;
Lindsten, T ;
Thompson, C ;
White, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :14127-14134
[10]
Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis [J].
Desagher, S ;
Osen-Sand, A ;
Nichols, A ;
Eskes, R ;
Montessuit, S ;
Lauper, S ;
Maundrell, K ;
Antonsson, B ;
Martinou, JC .
JOURNAL OF CELL BIOLOGY, 1999, 144 (05) :891-901